Philippe Beuzeboc

13.1k citations
227 papers · 10.0k · 5 hit papers · h-index 54

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Bone health and treatments
    • Cancer Treatment and Pharmacology

Papers in

    • Prostate Cancer Treatment and Research 60
    • Prostate Cancer Diagnosis and Treatment 33
    • Cancer Treatment and Pharmacology 19
    • HER2/EGFR in Cancer Research 17
    • Bone health and treatments 10

Philippe Beuzeboc

213 papers receiving 9.6k citations

Philippe Beuzeboc's Hit Papers

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes 2024 · 54 citations
540+4+8Years since publication100200300400500

Peers

Philippe Beuzeboc
Comparison fields: 5 of 126
  • Cancer Research 2.3k
  • Oncology 3.4k
  • Pulmonary and Respiratory Medicine 3.9k
  • Radiology, Nuclear Medicine and Imaging 1.1k
  • Surgery 1.8k
Replace Janine Mansi with:
Janine Mansi United Kingdom
Maria E. Cabanillas United States
Sandy Srinivas United States
Saby George United States
Umberto BASSO Italy
Frédéric Rolland France
Gilberto de Castro Junior Brazil
Lee S. Rosen United States
Maciej Jerzy Krzakowski Poland
Philippe Alexandre Cassier France
Philippe Beuzeboc relative to Janine Mansi United Kingdom Janine Mansi's profile →
Citations per field
00.5×1.5×2.2×
Janine Mansi · 1×
Citations per year

Countries citing papers authored by Philippe Beuzeboc

Since Specialization
Citations

This map shows the geographic impact of Philippe Beuzeboc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Beuzeboc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Beuzeboc more than expected).

Fields of papers citing papers by Philippe Beuzeboc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Beuzeboc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Beuzeboc. The network helps show where Philippe Beuzeboc may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Beuzeboc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Beuzeboc Line = papers co-authored together Philippe Beuzeboc links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013571
2 2012464
3
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Hit paper breakdown →
2021432
4 2007375
5
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015375
6 1994359
7 1996359
8
Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
Hit paper breakdown →
2023331
9 2003281
10 2009186
11 2015184
12 2009181
13 2009144
14 2014144
15 1989141
16 2001138
17 2008138
18 1995137
19 2014131
20 1996122

About Philippe Beuzeboc

Philippe Beuzeboc is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 227 papers that have together received 10.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (60 papers), Prostate Cancer Diagnosis and Treatment (33 papers), Bladder and Urothelial Cancer Treatments (30 papers), Breast Cancer Treatment Studies (24 papers), Cancer Treatment and Pharmacology (19 papers), HER2/EGFR in Cancer Research (17 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Bone health and treatments (10 papers). The work is most often cited by research in Cancer Research (2.3k citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (3.9k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Surgery (1.8k citations). Philippe Beuzeboc has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Pierre Pouillart, Stéphane Marie. Oudard, Thierry Dorval, Bernard Asselain, Suzy Scholl, Anne Vincent‐Salomon, Karim S. Fizazi, Jean‐Yves Pierga, Marc Jouve and T Palangié. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, European Urology, Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact